DICLEGIS - 55494-100-10 - (doxylamine succinate and pyridoxine hydrochloride)

Alphabetical Index


Drug Information of DICLEGIS

Product NDC: 55494-100
Proprietary Name: DICLEGIS
Non Proprietary Name: doxylamine succinate and pyridoxine hydrochloride
Active Ingredient(s): 10; 10    mg/1; mg/1 & nbsp;   doxylamine succinate and pyridoxine hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, DELAYED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of DICLEGIS

Product NDC: 55494-100
Labeler Name: Duchesnay USA, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021876
Marketing Category: NDA
Start Marketing Date: 20130515

Package Information of DICLEGIS

Package NDC: 55494-100-10
Package Description: 100 TABLET, DELAYED RELEASE in 1 BOTTLE (55494-100-10)

NDC Information of DICLEGIS

NDC Code 55494-100-10
Proprietary Name DICLEGIS
Package Description 100 TABLET, DELAYED RELEASE in 1 BOTTLE (55494-100-10)
Product NDC 55494-100
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name doxylamine succinate and pyridoxine hydrochloride
Dosage Form Name TABLET, DELAYED RELEASE
Route Name ORAL
Start Marketing Date 20130515
Marketing Category Name NDA
Labeler Name Duchesnay USA, Inc.
Substance Name DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
Strength Number 10; 10
Strength Unit mg/1; mg/1
Pharmaceutical Classes

Complete Information of DICLEGIS


General Information